Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post
Last Updated on: 13 April, 2025
Author: Getaka|Social: Getaka Financial Technology X (Earlier Twitter) Profile Getaka Financial Technology LinkedIn Logo

Jubilant Ingrevia Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: April 13, 2025, 9:38 pm

Market Cap 10,103 Cr.
Current Price 634
High / Low 885/462
Stock P/E49.0
Book Value 177
Dividend Yield0.79 %
ROCE9.97 %
ROE6.93 %
Face Value 1.00
PEG Ratio1.60

Stock P/E, Current Price, and Intrinsic Value Over Time

View Share Price Target for Jubilant Ingrevia Ltd

Competitors of Jubilant Ingrevia Ltd

Stock Name ⇩Market Cap ⇩Current Price ⇩High / Low ⇩Stock P/E ⇩Book Value ⇩Dividend Yield ⇩ROCE ⇩ROE ⇩Face Value ⇩
GRM Overseas Ltd 1,954 Cr. 326 330/12238.4 60.60.00 %12.9 %18.3 % 2.00
Freshtrop Fruits Ltd 89.5 Cr. 112 175/105 1450.00 %6.40 %51.6 % 10.0
Chamanlal Setia Exports Ltd 1,643 Cr. 318 447/18316.2 1310.71 %20.2 %17.4 % 2.00
Mangalam Global Enterprise Ltd 430 Cr. 13.1 17.0/8.6413.5 5.800.08 %13.8 %15.2 % 1.00
LT Foods Ltd 12,305 Cr. 354 452/18620.7 1050.56 %21.1 %19.3 % 1.00
Industry Average3,724.50 Cr310.2042.62114.410.33%12.89%17.86%3.50

All Competitor Stocks of Jubilant Ingrevia Ltd

Quarterly Result

MetricDec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024
Sales 1,2861,2961,1661,3041,1581,1451,0751,0209661,0741,0241,0451,057
Expenses 1,0741,1531,0251,1511,0071,043958902871983915921918
Operating Profit 2131421411531511021171189691110124138
OPM % 17%11%12%12%13%9%11%12%10%8%11%12%13%
Other Income 99107798991010109
Interest 56457611131514141512
Depreciation 30313131303032343436394040
Profit before tax 1871151161241227681805551668096
Tax % 31%40%31%32%25%31%29%28%30%43%26%26%27%
Net Profit 129697984925258573929495969
EPS in Rs 8.104.314.985.295.753.283.623.612.421.843.063.704.36

Last Updated: February 28, 2025, 7:00 pm

Below is a detailed analysis of the quarterly data for Jubilant Ingrevia Ltd based on the most recent figures (Dec 2024) and their trends compared to the previous period:

  • For Sales, as of Dec 2024, the value is 1,057.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,045.00 Cr. (Sep 2024) to 1,057.00 Cr., marking an increase of 12.00 Cr..
  • For Expenses, as of Dec 2024, the value is 918.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 921.00 Cr. (Sep 2024) to 918.00 Cr., marking a decrease of 3.00 Cr..
  • For Operating Profit, as of Dec 2024, the value is 138.00 Cr.. The value appears strong and on an upward trend. It has increased from 124.00 Cr. (Sep 2024) to 138.00 Cr., marking an increase of 14.00 Cr..
  • For OPM %, as of Dec 2024, the value is 13.00%. The value appears strong and on an upward trend. It has increased from 12.00% (Sep 2024) to 13.00%, marking an increase of 1.00%.
  • For Other Income, as of Dec 2024, the value is 9.00 Cr.. The value appears to be declining and may need further review. It has decreased from 10.00 Cr. (Sep 2024) to 9.00 Cr., marking a decrease of 1.00 Cr..
  • For Interest, as of Dec 2024, the value is 12.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 15.00 Cr. (Sep 2024) to 12.00 Cr., marking a decrease of 3.00 Cr..
  • For Depreciation, as of Dec 2024, the value is 40.00 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2024) which recorded 40.00 Cr..
  • For Profit before tax, as of Dec 2024, the value is 96.00 Cr.. The value appears strong and on an upward trend. It has increased from 80.00 Cr. (Sep 2024) to 96.00 Cr., marking an increase of 16.00 Cr..
  • For Tax %, as of Dec 2024, the value is 27.00%. The value appears to be increasing, which may not be favorable. It has increased from 26.00% (Sep 2024) to 27.00%, marking an increase of 1.00%.
  • For Net Profit, as of Dec 2024, the value is 69.00 Cr.. The value appears strong and on an upward trend. It has increased from 59.00 Cr. (Sep 2024) to 69.00 Cr., marking an increase of 10.00 Cr..
  • For EPS in Rs, as of Dec 2024, the value is 4.36. The value appears strong and on an upward trend. It has increased from 3.70 (Sep 2024) to 4.36, marking an increase of 0.66.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: March 6, 2025, 3:47 pm

MetricMar 2020Mar 2021Mar 2022Mar 2023Mar 2024TTM
Sales 06844,9494,7734,1364,201
Expenses 05674,1084,2243,7083,737
Operating Profit -0117841549427463
OPM % 17%17%11%10%11%
Other Income 0-1022322939
Interest 0731225355
Depreciation 022123122136154
Profit before tax -077709437268293
Tax % 0%30%33%30%32%
Net Profit -054477308183206
EPS in Rs -3.403.4129.9319.3111.4812.96
Dividend Payout % 0%10%17%26%43%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year2021-20222022-20232023-2024
YoY Net Profit Growth (%)783.33%-35.43%-40.58%
Change in YoY Net Profit Growth (%)0.00%-818.76%-5.15%

Jubilant Ingrevia Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 3 years from 2021-2022 to 2023-2024.

Growth

Compounded Sales Growth
10 Years:%
5 Years:%
3 Years:82%
TTM:0%
Compounded Profit Growth
10 Years:%
5 Years:%
3 Years:43%
TTM:0%
Stock Price CAGR
10 Years:%
5 Years:%
3 Years:9%
1 Year:15%
Return on Equity
10 Years:%
5 Years:%
3 Years:13%
Last Year:7%

Last Updated: Unknown

Balance Sheet

Last Updated: November 14, 2024, 9:34 pm

MonthMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Sep 2024
Equity Capital 0.051616161616
Reserves -01,9072,4172,6502,7222,800
Borrowings 0556238407740720
Other Liabilities 08881,1111,1761,2411,306
Total Liabilities 03,3663,7824,2494,7194,841
Fixed Assets 01,8051,7981,8462,5392,539
CWIP 065174525331455
Investments 050681519
Other Assets 01,4461,8041,8701,8341,829
Total Assets 03,3663,7824,2494,7194,841

Below is a detailed analysis of the balance sheet data for Jubilant Ingrevia Ltd based on the most recent figures (Sep 2024) and their trends compared to the previous period:

  • For Equity Capital, as of Sep 2024, the value is ₹16.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 16.00 Cr..
  • For Reserves, as of Sep 2024, the value is ₹2,800.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,722.00 Cr. (Mar 2024) to ₹2,800.00 Cr., marking an increase of 78.00 Cr..
  • For Borrowings, as of Sep 2024, the value is ₹720.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 740.00 Cr. (Mar 2024) to ₹720.00 Cr., marking a decrease of 20.00 Cr..
  • For Other Liabilities, as of Sep 2024, the value is ₹1,306.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,241.00 Cr. (Mar 2024) to ₹1,306.00 Cr., marking an increase of 65.00 Cr..
  • For Total Liabilities, as of Sep 2024, the value is ₹4,841.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 4,719.00 Cr. (Mar 2024) to ₹4,841.00 Cr., marking an increase of 122.00 Cr..
  • For Fixed Assets, as of Sep 2024, the value is ₹2,539.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 2,539.00 Cr..
  • For CWIP, as of Sep 2024, the value is ₹455.00 Cr.. The value appears strong and on an upward trend. It has increased from 331.00 Cr. (Mar 2024) to ₹455.00 Cr., marking an increase of 124.00 Cr..
  • For Investments, as of Sep 2024, the value is ₹19.00 Cr.. The value appears strong and on an upward trend. It has increased from 15.00 Cr. (Mar 2024) to ₹19.00 Cr., marking an increase of 4.00 Cr..
  • For Other Assets, as of Sep 2024, the value is ₹1,829.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,834.00 Cr. (Mar 2024) to ₹1,829.00 Cr., marking a decrease of 5.00 Cr..
  • For Total Assets, as of Sep 2024, the value is ₹4,841.00 Cr.. The value appears strong and on an upward trend. It has increased from 4,719.00 Cr. (Mar 2024) to ₹4,841.00 Cr., marking an increase of 122.00 Cr..

Notably, the Reserves (2,800.00 Cr.) exceed the Borrowings (720.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Reserves and Borrowings Chart

Cash Flow

MonthMar 2020Mar 2021Mar 2022Mar 2023Mar 2024
Cash from Operating Activity +0112453462430
Cash from Investing Activity +033-71-469-568
Cash from Financing Activity +0-72-41842144
Net Cash Flow073-36356

Free Cash Flow

MonthMar 2020Mar 2021Mar 2022Mar 2023Mar 2024
Free Cash Flow0.00-439.00603.00142.00-313.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

MonthMar 2020Mar 2021Mar 2022Mar 2023Mar 2024
Debtor Days251433950
Inventory Days601117146160
Days Payable685103113131
Cash Conversion Cycle167577280
Working Capital Days269596164
ROCE %8%29%16%10%

Financial Efficiency Indicators Chart

Share Holding Pattern

MonthMar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024
Promoters51.10%51.47%51.47%51.47%51.47%51.47%51.47%51.47%51.47%51.47%51.47%51.47%
FIIs11.21%10.19%9.24%8.40%7.73%6.15%6.30%6.35%6.58%6.55%7.22%6.89%
DIIs0.67%0.70%2.36%4.89%5.97%6.72%9.18%11.17%13.60%14.07%15.47%15.99%
Public36.82%37.44%36.72%35.03%34.62%34.83%32.22%30.17%27.53%27.10%25.09%24.90%
Others0.20%0.20%0.20%0.19%0.19%0.82%0.82%0.82%0.81%0.81%0.77%0.74%
No. of Shareholders1,91,4771,93,8581,95,7041,86,8951,85,0621,86,2941,73,5331,62,2021,50,3881,42,7361,25,3671,24,830

Shareholding Pattern Chart

No. of Shareholders

Mutual Fund Holdings

Fund NameNo of SharesAUM (%)Amount Invested (Cr)Previous Number of SharesPrevious DatePercentage Change
DSP Small Cap Fund5,188,6571.84217.82N/AN/AN/A
DSP Mid Cap Fund3,926,7221.14164.84N/AN/AN/A
Nippon India Small Cap Fund1,156,2990.1348.541,156,2992025-04-110%
DSP Top 100 Equity Fund1,082,1151.5445.431,082,1152025-04-120%
DSP Tiger Fund877,1611.4936.82N/AN/AN/A
DSP Equity Savings Fund148,7770.916.25N/AN/AN/A
Nippon India Nifty Smallcap 250 Index Fund44,2840.261.86N/AN/AN/A
Motilal Oswal Nifty Smallcap 250 Index Fund27,8020.261.17N/AN/AN/A
DSP Regular Savings Fund22,9590.540.97N/AN/AN/A
SBI Nifty Smallcap 250 Index Fund20,4060.260.86N/AN/AN/A

ROCE Trend

EPS Trend

Key Financial Ratios

MonthMar 24Mar 23Mar 22Mar 21Mar 20
FaceValue 1.001.001.001.001.00
Basic EPS (Rs.) 11.5619.3429.9820.78-3.31
Diluted EPS (Rs.) 11.5519.3429.9720.78-3.31
Cash EPS (Rs.) 20.1927.0337.754.80-3.32
Book Value[Excl.RevalReserv]/Share (Rs.) 173.27167.72153.06120.73-2.32
Book Value[Incl.RevalReserv]/Share (Rs.) 173.27167.72153.06120.73-2.32
Revenue From Operations / Share (Rs.) 261.78300.23311.3442.950.00
PBDIT / Share (Rs.) 28.8936.5254.317.52-3.32
PBIT / Share (Rs.) 20.2728.8346.556.13-3.32
PBT / Share (Rs.) 16.9427.4744.604.86-3.32
Net Profit / Share (Rs.) 11.5719.3529.993.41-3.32
NP After MI And SOA / Share (Rs.) 11.5819.3429.993.41-3.32
PBDIT Margin (%) 11.0312.1617.4417.500.00
PBIT Margin (%) 7.749.6014.9514.270.00
PBT Margin (%) 6.479.1514.3211.310.00
Net Profit Margin (%) 4.426.449.637.940.00
NP After MI And SOA Margin (%) 4.426.449.637.940.00
Return on Networth / Equity (%) 6.6811.5319.592.820.00
Return on Capital Employeed (%) 9.2914.8826.963.93143.10
Return On Assets (%) 3.867.2212.551.60-332.00
Long Term Debt / Equity (X) 0.150.050.040.230.00
Total Debt / Equity (X) 0.260.140.090.230.00
Asset Turnover Ratio (%) 0.921.161.380.410.00
Current Ratio (X) 1.381.541.681.590.30
Quick Ratio (X) 0.650.660.810.910.30
Inventory Turnover Ratio (X) 2.062.844.080.000.00
Dividend Payout Ratio (NP) (%) 43.1825.849.520.000.00
Dividend Payout Ratio (CP) (%) 24.7518.497.560.000.00
Earning Retention Ratio (%) 56.8274.1690.480.000.00
Cash Earning Retention Ratio (%) 75.2581.5192.440.000.00
Interest Coverage Ratio (X) 8.6726.9027.9116.340.00
Interest Coverage Ratio (Post Tax) (X) 4.4715.2516.4110.180.00
Enterprise Value (Cr.) 7789.816031.887331.494498.030.00
EV / Net Operating Revenue (X) 1.881.261.486.570.00
EV / EBITDA (X) 17.0710.398.4937.570.00
MarketCap / Net Operating Revenue (X) 1.731.201.446.080.00
Retention Ratios (%) 56.8174.1590.470.000.00
Price / BV (X) 2.612.152.942.160.00
Price / Net Operating Revenue (X) 1.731.201.446.080.00
EarningsYield 0.020.050.060.010.00

After reviewing the key financial ratios for Jubilant Ingrevia Ltd, here is a detailed analysis based on the latest available data and recent trends:

  • For FaceValue, as of Mar 24, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 1.00.
  • For Basic EPS (Rs.), as of Mar 24, the value is 11.56. This value is within the healthy range. It has decreased from 19.34 (Mar 23) to 11.56, marking a decrease of 7.78.
  • For Diluted EPS (Rs.), as of Mar 24, the value is 11.55. This value is within the healthy range. It has decreased from 19.34 (Mar 23) to 11.55, marking a decrease of 7.79.
  • For Cash EPS (Rs.), as of Mar 24, the value is 20.19. This value is within the healthy range. It has decreased from 27.03 (Mar 23) to 20.19, marking a decrease of 6.84.
  • For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 173.27. It has increased from 167.72 (Mar 23) to 173.27, marking an increase of 5.55.
  • For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 173.27. It has increased from 167.72 (Mar 23) to 173.27, marking an increase of 5.55.
  • For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 261.78. It has decreased from 300.23 (Mar 23) to 261.78, marking a decrease of 38.45.
  • For PBDIT / Share (Rs.), as of Mar 24, the value is 28.89. This value is within the healthy range. It has decreased from 36.52 (Mar 23) to 28.89, marking a decrease of 7.63.
  • For PBIT / Share (Rs.), as of Mar 24, the value is 20.27. This value is within the healthy range. It has decreased from 28.83 (Mar 23) to 20.27, marking a decrease of 8.56.
  • For PBT / Share (Rs.), as of Mar 24, the value is 16.94. This value is within the healthy range. It has decreased from 27.47 (Mar 23) to 16.94, marking a decrease of 10.53.
  • For Net Profit / Share (Rs.), as of Mar 24, the value is 11.57. This value is within the healthy range. It has decreased from 19.35 (Mar 23) to 11.57, marking a decrease of 7.78.
  • For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 11.58. This value is within the healthy range. It has decreased from 19.34 (Mar 23) to 11.58, marking a decrease of 7.76.
  • For PBDIT Margin (%), as of Mar 24, the value is 11.03. This value is within the healthy range. It has decreased from 12.16 (Mar 23) to 11.03, marking a decrease of 1.13.
  • For PBIT Margin (%), as of Mar 24, the value is 7.74. This value is below the healthy minimum of 10. It has decreased from 9.60 (Mar 23) to 7.74, marking a decrease of 1.86.
  • For PBT Margin (%), as of Mar 24, the value is 6.47. This value is below the healthy minimum of 10. It has decreased from 9.15 (Mar 23) to 6.47, marking a decrease of 2.68.
  • For Net Profit Margin (%), as of Mar 24, the value is 4.42. This value is below the healthy minimum of 5. It has decreased from 6.44 (Mar 23) to 4.42, marking a decrease of 2.02.
  • For NP After MI And SOA Margin (%), as of Mar 24, the value is 4.42. This value is below the healthy minimum of 8. It has decreased from 6.44 (Mar 23) to 4.42, marking a decrease of 2.02.
  • For Return on Networth / Equity (%), as of Mar 24, the value is 6.68. This value is below the healthy minimum of 15. It has decreased from 11.53 (Mar 23) to 6.68, marking a decrease of 4.85.
  • For Return on Capital Employeed (%), as of Mar 24, the value is 9.29. This value is below the healthy minimum of 10. It has decreased from 14.88 (Mar 23) to 9.29, marking a decrease of 5.59.
  • For Return On Assets (%), as of Mar 24, the value is 3.86. This value is below the healthy minimum of 5. It has decreased from 7.22 (Mar 23) to 3.86, marking a decrease of 3.36.
  • For Long Term Debt / Equity (X), as of Mar 24, the value is 0.15. This value is below the healthy minimum of 0.2. It has increased from 0.05 (Mar 23) to 0.15, marking an increase of 0.10.
  • For Total Debt / Equity (X), as of Mar 24, the value is 0.26. This value is within the healthy range. It has increased from 0.14 (Mar 23) to 0.26, marking an increase of 0.12.
  • For Asset Turnover Ratio (%), as of Mar 24, the value is 0.92. It has decreased from 1.16 (Mar 23) to 0.92, marking a decrease of 0.24.
  • For Current Ratio (X), as of Mar 24, the value is 1.38. This value is below the healthy minimum of 1.5. It has decreased from 1.54 (Mar 23) to 1.38, marking a decrease of 0.16.
  • For Quick Ratio (X), as of Mar 24, the value is 0.65. This value is below the healthy minimum of 1. It has decreased from 0.66 (Mar 23) to 0.65, marking a decrease of 0.01.
  • For Inventory Turnover Ratio (X), as of Mar 24, the value is 2.06. This value is below the healthy minimum of 4. It has decreased from 2.84 (Mar 23) to 2.06, marking a decrease of 0.78.
  • For Dividend Payout Ratio (NP) (%), as of Mar 24, the value is 43.18. This value is within the healthy range. It has increased from 25.84 (Mar 23) to 43.18, marking an increase of 17.34.
  • For Dividend Payout Ratio (CP) (%), as of Mar 24, the value is 24.75. This value is within the healthy range. It has increased from 18.49 (Mar 23) to 24.75, marking an increase of 6.26.
  • For Earning Retention Ratio (%), as of Mar 24, the value is 56.82. This value is within the healthy range. It has decreased from 74.16 (Mar 23) to 56.82, marking a decrease of 17.34.
  • For Cash Earning Retention Ratio (%), as of Mar 24, the value is 75.25. This value exceeds the healthy maximum of 70. It has decreased from 81.51 (Mar 23) to 75.25, marking a decrease of 6.26.
  • For Interest Coverage Ratio (X), as of Mar 24, the value is 8.67. This value is within the healthy range. It has decreased from 26.90 (Mar 23) to 8.67, marking a decrease of 18.23.
  • For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 4.47. This value is within the healthy range. It has decreased from 15.25 (Mar 23) to 4.47, marking a decrease of 10.78.
  • For Enterprise Value (Cr.), as of Mar 24, the value is 7,789.81. It has increased from 6,031.88 (Mar 23) to 7,789.81, marking an increase of 1,757.93.
  • For EV / Net Operating Revenue (X), as of Mar 24, the value is 1.88. This value is within the healthy range. It has increased from 1.26 (Mar 23) to 1.88, marking an increase of 0.62.
  • For EV / EBITDA (X), as of Mar 24, the value is 17.07. This value exceeds the healthy maximum of 15. It has increased from 10.39 (Mar 23) to 17.07, marking an increase of 6.68.
  • For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 1.73. This value is within the healthy range. It has increased from 1.20 (Mar 23) to 1.73, marking an increase of 0.53.
  • For Retention Ratios (%), as of Mar 24, the value is 56.81. This value is within the healthy range. It has decreased from 74.15 (Mar 23) to 56.81, marking a decrease of 17.34.
  • For Price / BV (X), as of Mar 24, the value is 2.61. This value is within the healthy range. It has increased from 2.15 (Mar 23) to 2.61, marking an increase of 0.46.
  • For Price / Net Operating Revenue (X), as of Mar 24, the value is 1.73. This value is within the healthy range. It has increased from 1.20 (Mar 23) to 1.73, marking an increase of 0.53.
  • For EarningsYield, as of Mar 24, the value is 0.02. This value is below the healthy minimum of 5. It has decreased from 0.05 (Mar 23) to 0.02, marking a decrease of 0.03.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value of Jubilant Ingrevia Ltd as of April 13, 2025 is: 484.63

Calculation basis:

  • Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

As of April 13, 2025, Jubilant Ingrevia Ltd is Overvalued by 23.56% compared to the current share price 634.00

Intrinsic Value of Jubilant Ingrevia Ltd as of April 13, 2025 is: 632.97

Calculation basis:

  • Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
  • EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.

As of April 13, 2025, Jubilant Ingrevia Ltd is Overvalued by 0.16% compared to the current share price 634.00

Last 5 Year EPS CAGR: 30.61%

*Investments are subject to market risks

Strength and Weakness

StrengthWeakness
  1. The company has higher reserves (2,082.67 cr) compared to borrowings (443.50 cr), indicating strong financial stability.
  2. The company has shown consistent growth in sales (116.67 cr) and profit (297.33 cr) over the years.
  1. The stock has a low average ROCE of 12.60%, which may not be favorable.
  2. The stock has a high average Working Capital Days of 90.60, which may not be favorable.
  3. The stock has a high average Cash Conversion Cycle of 75.20, which may not be favorable.

Stock Analysis

  • Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Jubilant Ingrevia Ltd:
    1. Net Profit Margin: 4.42%
      • Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
    2. ROCE: 9.29% (Industry Average ROCE: 12.89%)
      • ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
    3. ROE%: 6.68% (Industry Average ROE: 16.38%)
      • ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
    4. Interest Coverage Ratio (Post Tax): 4.47
      • Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
    5. Quick Ratio: 0.65
      • Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
    6. Stock P/E: 49 (Industry average Stock P/E: 35.52)
      • Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
    7. Total Debt / Equity: 0.26
      • Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
    The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
    Stock Rating:

About the Company - Qualitative Analysis

Jubilant Ingrevia Ltd. is a Public Limited Listed company incorporated on 23/10/2019 and has its registered office in the State of Uttar Pradesh, India. Company's Corporate Identification Number(CIN) is L24299UP2019PLC122657 and registration number is 122657. Currently Company is involved in the business activities of Manufacture of basic chemicals. Company's Total Operating Revenue is Rs. 3987.25 Cr. and Equity Capital is Rs. 15.93 Cr. for the Year ended 31/03/2024.
INDUSTRYADDRESSCONTACT
Agricultural ProductsBhartiagram, Amroha District Uttar Pradesh 244223investors.ingrevia@jubl.com
http://www.jubilantingrevia.com
Management
NamePosition Held
Mr. Shyam S BhartiaChairman
Mr. Hari S BhartiaCo-Chairman & WholeTime Director
Mr. Deepak JainManaging Director & CEO
Mr. Chandan SinghCo-CEO & Whole Time Director
Mr. Priyavrat BhartiaDirector
Mr. Arjun Shanker BhartiaDirector
Ms. Sudha PillaiIndependent Director
Mr. Sushil Kumar RoongtaIndependent Director
Mr. Arun SethIndependent Director
Mr. Pradeep BanerjeeIndependent Director
Mr. Siraj Azmat ChaudhryIndependent Director
Ms. Ameeta ChatterjeeIndependent Director

FAQ

What is the intrinsic value of Jubilant Ingrevia Ltd?

Jubilant Ingrevia Ltd's intrinsic value (as of 13 April 2025) is ₹484.63 — 23.56% lower the current market price of 634.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 10,103 Cr. market cap, FY2025-2026 high/low of ₹885/462, reserves of 2,800 Cr, and liabilities of 4,841 Cr.

What is the Market Cap of Jubilant Ingrevia Ltd?

The Market Cap of Jubilant Ingrevia Ltd is 10,103 Cr..

What is the current Stock Price of Jubilant Ingrevia Ltd as on 13 April 2025?

The current stock price of Jubilant Ingrevia Ltd as on 13 April 2025 is 634.

What is the High / Low of Jubilant Ingrevia Ltd stocks in FY 2025-2026?

In FY 2025-2026, the High / Low of Jubilant Ingrevia Ltd stocks is ₹885/462.

What is the Stock P/E of Jubilant Ingrevia Ltd?

The Stock P/E of Jubilant Ingrevia Ltd is 49.0.

What is the Book Value of Jubilant Ingrevia Ltd?

The Book Value of Jubilant Ingrevia Ltd is 177.

What is the Dividend Yield of Jubilant Ingrevia Ltd?

The Dividend Yield of Jubilant Ingrevia Ltd is 0.79 %.

What is the ROCE of Jubilant Ingrevia Ltd?

The ROCE of Jubilant Ingrevia Ltd is 9.97 %.

What is the ROE of Jubilant Ingrevia Ltd?

The ROE of Jubilant Ingrevia Ltd is 6.93 %.

What is the Face Value of Jubilant Ingrevia Ltd?

The Face Value of Jubilant Ingrevia Ltd is 1.00.

Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in Jubilant Ingrevia Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE